WeChat Program Improves Weight Loss and Steatosis
Researchers at Xinhua Hospital in Shanghai report a 6-month randomized controlled trial (n=89) comparing a WeChat mini-program lifestyle intervention to standard care among overweight or obese adults with MAFLD. The intervention group achieved greater weight loss (60% ≥5%, 24.4% ≥10%) and improved hepatic steatosis (CAP reduction/normalization) and metabolic markers. The study suggests a scalable, low-cost approach suitable for primary care.
Scoring Rationale
Registered, peer-reviewed RCT shows clear benefits; single-center, small sample limits broader generalizability and long-term certainty.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problemsStep-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
Sources
- Read OriginalTherapeutic Effects of a WeChat Mini-Program on Metabolic Dysfunction–Associated Fatty Liver Disease: Randomized Controlled Trialjmir.org
